首页> 外国专利> APPLICATION OF Razagilin for the treatment of olfactory dysfunction

APPLICATION OF Razagilin for the treatment of olfactory dysfunction

机译:雷扎吉林在嗅觉功能障碍中的应用

摘要

1. A method of treating a symptom of olfactory dysfunction in a subject suffering from olfactory dysfunction, comprising: a) determining the subject as suffering from olfactory dysfunction, and b) periodically administering to the subject thus determined an amount of R (+) - N-propargyl-1-aminoindan or its pharmaceutically an acceptable salt effective to treat a subject. 2. The method of claim 1, wherein the subject is a subject without Parkinson's disease. A method for reducing the progression of olfactory dysfunction in a subject without Parkinson’s disease suffering from olfactory dysfunction, comprising periodically administering to the subject an amount of R (+) - N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof effective to reduce the progression of olfactory dysfunction in a subject without Parkinson's disease. 4. A method of inhibiting olfactory function loss in a subject without Parkinson's disease, comprising periodically administering to the subject an amount of R (+) - N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof effective to inhibit olfactory function loss in a subject without Parkinson's disease. The method according to claim 1, wherein the amount of R (+) - N-propargyl-1-aminoindan or its pharmaceutically acceptable salt is from 0.01 mg to 5 mg per day. The method according to claim 5, wherein the amount of R (+) - N-propargyl-1-aminoindan or its pharmaceutically acceptable salt is 0.5 mg per day. The method of claim 5, wherein the amount of R (+) - N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof is 2 mg per day. The method according to claim 5, in which the amount of R (+) - N-propargyl-1-aminoindan or its pharmaceutically acceptable salt is
机译:1.一种治疗患有嗅觉功能障碍的受试者的嗅觉功能障碍的症状的方法,其包括:a)确定该受试者患有嗅觉功能障碍,和b)定期向该受试者施用由此确定的R(+)的量- N-炔丙基-1-氨基茚满或其药学上可接受的有效治疗对象的盐。 2.根据权利要求1所述的方法,其中,所述受试者是没有帕金森氏病的受试者。在没有患有嗅觉功能障碍的帕金森氏病的患者中减少嗅觉功能障碍的进展的方法,其包括定期向所述对象施用有效降低量的R(+)-N-炔丙基-1-氨基茚满或其药学上可接受的盐。没有帕金森氏病的受试者中嗅觉功能障碍的进展。 4.一种在没有帕金森氏病的受试者中抑制嗅觉功能丧失的方法,其包括定期向所述受试者施用一定量的R(+)-N-炔丙基-1-氨基茚满或其药学上可接受的盐,以有效抑制帕金森氏症的嗅觉功能丧失。没有帕金森氏病的受试者。 2.根据权利要求1的方法,其中R(+)-N-炔丙基-1-氨基茚满或其可药用盐的量为每天0.01mg至5mg。 6.根据权利要求5的方法,其中R(+)-N-炔丙基-1-氨基茚满或其可药用盐的量为每天0.5mg。 6.权利要求5的方法,其中R(+)-N-炔丙基-1-氨基茚满或其药学上可接受的盐的量为每天2mg。 6.根据权利要求5的方法,其中R(+)-N-炔丙基-1-氨基茚满或其药学上可接受的盐的量为

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号